T-Cells May Be Sufficient to Provide Protection from COVID-19, Finds New Study
Data released from a prospective cohort study in key workers in the UK demonstrates that SARS-CoV-2 reactive T cells may be sufficient to give protection from COVID-19 and that serology alone may underestimate those at lower risk of clinical SARS-CoV-2 infection. More...11 Nov 2020
Qiagen and TScan Therapeutics to Jointly Develop T Cell-Based Laboratory Test for COVID-19 Immune Response
QIAGEN N.V. (Venlo, Netherlands) and TScan Therapeutics (Waltham, MA, USA) have entered into a research license and option agreement to develop T cell-based laboratory tests for detecting prior exposure to the novel coronavirus, SARS-CoV-2, using discoveries from TScan’s high-throughput TCR/Target discovery platform, T-Scan. More...11 Nov 2020
Pfizer Coronavirus Vaccine More Than 90% Effective in Preventing COVID-19 in Phase 3 Study
Pfizer Inc. (New York, NY, USA) and Biopharmaceutical New Technologies (BioNTech Mainz, Germany) have announced that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection. More...10 Nov 2020
Lung Ultrasound Scan Findings Can Help Identify False-Negative COVID-19 Test Results
A new study has found that the integration of lung ultrasound (LUS) with clinical evaluation is associated with increased sensitivity for the diagnosis of COVID-19 pneumonia, and may facilitate the identification of false negative SARS-CoV-2 RT-PCR results. More...10 Nov 2020
Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Documentation System For Blood Banks
HettInfo II
New
Cannulating Sphincterotome
TRUEtome
In Other News
Researchers Developing 'Lab-in-Box' Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR
Fujirebio Europe Partners with Centogene to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing
PerkinElmer’s EUROIMMUN Launches Anti-SARS-CoV-2 QuantiVac ELISA (IgG) to Measure IgG Antibodies Against SARS-CoV-2 S1 Antigen
Antibodies Created During Infection with Common Cold Coronaviruses Can Also Target SARS-CoV-2
Study Offers Insight into Designing COVID-19 Drugs to Dually Inhibit SARS-CoV-2 Entry and Replication
FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection
Nasal Antiviral Spray That Blocks Transmission of SARS-CoV-2 in Ferrets Could Halt Spread of COVID-19
Regeneron to Continue Trial Evaluating Antibody Cocktail REGN-COV2 in Hospitalized COVID-19 Patients
Carolina Liquid Chemistries COVID-19 Antibody Test Receives FDA EUA for Use with Fingerstick Blood Samples at POC
AI System Distinguish COVID-19 from Flu and Other Respiratory Diseases in Less Than Three Seconds
AstraZeneca COVID-19 Vaccine Could Be Ready for Large-Scale Immunization as Early as December, Says CEO
Highly Automated Microlab Half the Size of Credit Card Detects COVID-19 in 30 Minutes
Rapid Changes in Inflammation Biomarker Could Be Key Predictor of COVID-19 Outcomes
COVID-19 Antigen Tests for Rapid Detection of SARS-CoV-2 Can Provide False Positive Results, Warns FDA
New Bacterial Delivery System to Administer COVID-19 Vaccine Directly to Respiratory Tract as Nasal Spray
Statins Reduces Mortality by 22% to 25% in COVID-19 Patients
COVID-19 Test Uses DNA Nanoswitch Technology to Detect SARS-CoV-2 Virus
Scientists Discover Fastest Way to Identify Potent, Neutralizing Human Monoclonal Antibodies Against SARS-CoV-2
Free Artificial Intelligence Software for Rapid Detection of COVID-19 from CT Scans Launched Globally
ORAcollect RNA Saliva Collection Device for SARS CoV-2 Granted FDA Emergency Use Authorization
Nasally Administered Drug Could Generate Nasal Mucosal Immunity Against SARS-CoV-2
Fujifilm Launches Droplet-Reduction Mouthpiece to Reduce COVID-19 Risk in Endoscopic Examinations
Artificial Intelligence Algorithm Analyzes Chest X-Rays to Detect COVID-19 in Seconds
